Nephros, Inc. (NASDAQ:NEPH) Short Interest Up 59.4% in May

Nephros, Inc. (NASDAQ:NEPH) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 5,100 shares, a growth of 59.4% from the May 15th total of 3,200 shares. Based on an average daily trading volume, of 18,600 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the shares of the company are short sold.

Institutional Investors Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC bought a new stake in Nephros, Inc. (NASDAQ:NEPH) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros at the end of the most recent reporting period. Hedge funds and other institutional investors own 41.10% of the company’s stock.

Nephros Trading Down 12.1%

NASDAQ NEPH traded down $0.47 on Monday, hitting $3.40. 140,486 shares of the company’s stock traded hands, compared to its average volume of 15,032. The firm has a market capitalization of $36.04 million, a PE ratio of -37.78 and a beta of 0.96. The firm’s 50-day moving average price is $2.42 and its two-hundred day moving average price is $1.88. Nephros has a 1-year low of $1.36 and a 1-year high of $4.26.

Nephros (NASDAQ:NEPH) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.05 earnings per share for the quarter. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%. The business had revenue of $4.88 million during the quarter, compared to analyst estimates of $3.67 million.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.